TVRD

Tvardi Therapeutics
TVRD

Overview Fund Trends Analyst Outlook Journalist POV

69 hedge funds and large institutions have $4.17M invested in Tvardi Therapeutics in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 34 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

85% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 34

Holders
69
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$29.2K
2
+$13.3K
3
+$10.7K
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.1K
5
C
Certuity
Florida
+$3.91K

Top Sellers

1
-$253K
2
-$152K
3
-$107K
4
Goldman Sachs
Goldman Sachs
New York
-$101K
5
Jane Street
Jane Street
New York
-$99.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$230
52
$227
53
$222
54
$162
55
$154
56
$81
57
$77
58
$68
59
$54
60
$46
61
$31
62
$30
63
$25
64
$12
65
$11
66
$11
67
$1
68
$1
69
–
70
–
71
–
72
–
73
–
74
–
75
–
1 2
3
4